Eugenia Settecase

Ms. Eugenia Settecase

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2025 in Journal of Periodontal Research
Verified
Journal Article
Open access
LSLucia Schiavon
Lucia Schiavon
Leonardo ManciniLeonardo Mancini
Leonardo Mancini
ESEugenia Settecase
Eugenia Settecase
RJRonald E. Jung
Ronald E. Jung
Tim JodaTim Joda
Tim Joda
Aim: This systematic review and network meta‐analysis aimed to answer the PICO question: In patients undergoing immediate implant placement (IIP) [P], does Computer‐Assisted Implant Surgery (CAIS) [I] lead to higher accuracy [O] compared to free‐hand (FH) [C] implant placement? Methods: A systematic search of MEDLINE, Scopus, and Cochrane databases was conducted for randomized clinical trials (RCTs) published between January 2014 and September 2024, comparing accuracy of CAIS and FH for IIP. Two reviewers screened the studies and extracted data for a network meta‐analysis. Results: Of 2064 records screened, 7 RCTs (338 implants and 291 patients) met the inclusion criteria. These RCTs evaluated FH and dynamic, full static, and partial static CAIS for single or partial implant placement. No RCTs analyzing robotic‐assisted implant surgery (RAIS) were found. In 71.4% of the studies, IIP was performed in the anterior maxilla using a flapless approach. Accuracy was assessed by angular, cervical, and apical deviations between planned and real implant positions. All CAIS methods demonstrated significantly higher accuracy than FH ( p < 0.05), but no significant differences were observed between CAIS approaches. Conclusions: CAIS significantly improves IIP accuracy, enhancing 3D implant positioning and prosthetic outcomes. All CAIS techniques revealed comparable accuracy, allowing clinicians to select the most suitable approach for each patient. Trial Registration: PROSPERO identification number: CRD42024554241

25 April 2026 in Journal of Periodontal Research
Verified
Journal Article
Open access
SSSofya Sadilina
Sofya Sadilina
SQSyed Majeed Quadri
Syed Majeed Quadri
RJRonald E. Jung
Ronald E. Jung
ESEugenia Settecase
Eugenia Settecase
MBMarc Balmer
Marc Balmer
Tim JodaTim Joda
Tim Joda
Aim: This updated systematic review aimed to synthesize and evaluate the available evidence on the use of augmented reality (AR), mixed reality (MR), and virtual reality (VR) technologies in dental medicine and education. Both qualitative synthesis and quantitative analysis through pairwise meta‐analysis, where applicable, were performed to assess their effectiveness and potential applications in clinical and educational settings. Methods: A systematic electronic search was conducted, incorporating an updated search strategy from the original publication to reflect updated terminology, for articles published between January 1, 2019, and July 14, 2025. Articles reporting the use of AR, MR, or VR in clinical treatment or dental education were eligible for inclusion. Data on study characteristics, target population, dental discipline, application concept, type of reality, primary and secondary outcomes were extracted. Pairwise frequentist meta‐analysis was conducted on randomized controlled trials (RCTs) assessing VR and objective stress‐related clinical parameters such as heart rate. Study quality was appraised using the corresponding scale according to the study design. Results: A total of 110 studies, reporting the use of AR, MR or VR, encompassing 8573 participants, were included. VR was the most frequently investigated technology ( n = 94), followed by AR ( n = 11) and MR ( n = 2). Most studies evaluated multiple applications: clinical or patient‐centered applications were evaluated in 71 trials, operator‐ or clinician‐orientated applications in 33, and educational applications in 132 studies. Among primary outcomes, patient‐reported ( n = 30) and educational outcomes ( n = 57) predominated, whereas clinical, clinician‐, and operator‐related outcomes were less frequently assessed. Results from the pairwise meta‐analyses of RCTs showed that VR significantly reduced anxiety levels in children patients when compared to tell‐show‐do techniques (SMD = −1.32, 95% CI −1.93 to −0.72); meanwhile, there was a borderline significant reduction in heart rate levels of children patients under the VR technique compared to tell‐show‐do technique (MD = −3.26, 95% CI −6.51 to −0.00). On the other hand, no significant differences were found in terms of physiological and reported outcomes in adult patients. Conclusion: AR, MR and VR are increasingly used in dental medicine and education, mainly in undergraduate and postgraduate training. Current evidence supports the effectiveness of immersive technologies, particularly VR, in enhancing learning outcomes for students and improving patient experience, especially in anxiety and pain management. However, conclusions are limited by heterogeneity and a small number of high‐quality studies, with overall low to moderate certainty of evidence. Trial Registration: PROSPERO number: CDR42023403360 and date of registration 10/03/2023. Start date of systematic review 13/03/2023.

30 June 2023 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
BIBoris Itkin
Boris Itkin
SSSamanta Straminsky
Samanta Straminsky
HCHernán Cáceres
Hernán Cáceres
MOMariana Onassis
Mariana Onassis
AGAgustín Emilio García
Agustín Emilio García
Ariel BardachAriel Bardach
Ariel Bardach
Objectives. To compare the mortality of unvaccinated oncology patients who received chemotherapy or immunotherapy during the pandemic with those treated before the pandemic. Materials and methods. We conducted a cohort study in four tertiary hospitals in Argentina. Outpatients with a solid neoplasm of any stage on cytotoxic or intravenous immune therapy were eligible. The pandemic cohort was enrolled during the initial phase of the outbreak and compared with a cohort from a pre-pandemic period using propensity score matching (PSM). Subjects were matched for age, sex, health insurance, severe COVID-19 complications risk, performance status, cancer and treatment type, treatment line, and body mass index. All-cause mortality was estimated in both cohorts after the 6-month follow-up. Results. Out of 169 patients recruited between April and August 2020 to the pandemic and 377 to the pre-pandemic cohorts in the same period of 2019, 168 were matched. After PSM, all-cause mortality was 17.9% in the pandemic and 18.5% in the pre-pandemic cohort, Risk Ratio: 0.97 (95% confidence interval: 0.61-1.52, p=0.888). In the pandemic cohort, 30/168 patients died - none of them from COVID-19 infection. Conclusions. We failed to demonstrate an increment in the mortality of unvaccinated, ambulatory patients on active intravenous anticancer treatment exposed to the COVID-19 pandemic.

6 July 2026 in Journal of Periodontal Research
Verified
Journal Article
Open access
MPMiha Pirc
Miha Pirc
ESEugenia Settecase
Eugenia Settecase
MLMargherita Giorgia Liguori
Margherita Giorgia Liguori
TJTobias Janson
Tobias Janson
RJRonald Ernst Jung
Ronald Ernst Jung
Tim JodaTim Joda
Tim Joda
This registry-based analysis provides a longitudinal overview of implant therapy within the maxillary esthetic zone over a 15-year period. The data suggest three developments: (1) increasing integration of digital workflows through CAIS; (2) a cautious tendency toward earlier implant placement protocols; (3) a gradual reduction in simultaneous guided bone augmentation.

19 August 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
LRLaura Rüegg
Laura Rüegg
SSSofya Sadilina
Sofya Sadilina
ESEugenia Settecase
Eugenia Settecase
RJRonald E. Jung
Ronald E. Jung
MSMurali Srinivasan
Murali Srinivasan
Tim JodaTim Joda
Tim Joda
Objectives: The objectives of this study were to assess the association between oral health-related quality of life (OHRQoL) and depressive symptoms among older adults in Canton Zurich, Switzerland, and to explore domain-specific variations. Methods: This pilot cross-sectional study included aging adults aged ≥65 years recruited from a university-based geriatric dental clinic in Zurich between 1 January and 31 March 2025. Participants completed paper-based questionnaires to assess their systemic and oral health, their quality of life (OHIP-14), and depressive symptoms (PHQ-8). Associations were assessed using Spearman’s rank correlation (ρ) with 95% confidence intervals estimated via bootstrap resampling. Domain-level analyses were conducted to explore the structure of the association, and a multivariable linear regression was used to assess whether the association persisted after adjustment. Results: A total of 108 participants were included (mean age of 76.2 ± 7.2 years; 53.4% male). Overall levels of OHRQoL and depressive symptoms were low. Higher OHIP-14 scores were moderately associated with higher PHQ-8 scores (ρ = 0.50; p-value < 0.01; 95% CI: 0.34–0.65). This association was consistent across PHQ-8 severity categories and remained significant after adjustment (β = 0.14; 95% CI: 0.06–0.22; p < 0.001). Domain-level analyses indicated stronger association in psychosocial and pain-related domains than for functional limitation. Conclusions: The study demonstrates that poorer OHRQoL was moderately associated with higher depressive symptoms, independently of the covariates examined, particularly in psychosocial domains. These findings suggest that OHRQoL reflects broader experiential and psychological dimensions of health beyond oral function alone, highlighting its relevance for oral health assessment in older adults. As the findings are based on a convenience sample of clinic attendees, larger population-based longitudinal studies are needed to clarify these relationships further.